Impact of Hip Flexors Isokinetic Strengthening on Gait Capacities in Subacute Stroke Patients
NCT ID: NCT02917850
Last Updated: 2018-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2016-08-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Mechanical Gait Repetitive Training Technique in Hemiparetic Stroke Patients (AVC)
NCT00284115
Impact of Prolonged Physical Therapy on Gait Performance of Chronic Phase Stroke Patients
NCT00658710
Muscular Strengthening for Paretic Knee Flexor and Extensor by Conventional Physiotherapy on Chronic Hemiplegic Stroke Patients
NCT00570570
Gait Perturbations to Improve Balance Post-stroke
NCT04314830
Gait Recovery After Stroke
NCT06806748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Isokinetic
Patients who benefit from the hip flexors isokinetic strengthening rehabilitation program
Isokinetic hip flexors strengthening
Isokinetic excentric strengthening of paretic hip flexors, 3/w during 6 weeks, in addition to conventional rehabilitation 7/w.
Conventional rehabilitation
Conventional rehabilitation 10/w during 6 weeks
Control
Patients who benefit from a conventional rehabilitation program
Conventional rehabilitation
Conventional rehabilitation 10/w during 6 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Isokinetic hip flexors strengthening
Isokinetic excentric strengthening of paretic hip flexors, 3/w during 6 weeks, in addition to conventional rehabilitation 7/w.
Conventional rehabilitation
Conventional rehabilitation 10/w during 6 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At the subacute phase
* Able to walk at least 10m with or without assistive devices
* Hip flexors strength on the paretic side \> 2/5 (MRC)
Exclusion Criteria
* Contraindications to physical activity (severe arterial hypertension, aortic valvulopathy, severe PAD...)
* History of muscular or joint disorders on the paretic hip
* Subject unable to deliver an informed written consent (due to aphasia, cognitive or psychiatric disorders...)
* Protected persons
* Pregnancy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Etienne Allart, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A00366-45
Identifier Type: OTHER
Identifier Source: secondary_id
2015_32
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.